Progressive Multifocal Leukoencephalopathy (pml) - Infectious Diseases

Relevant Publications

Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serum.

Issue Release: 2024

Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentration.

Issue Release: 2024

Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification.

Issue Release: 2024

Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient.

Issue Release: 2024

Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report.

Issue Release: 2024

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.

Issue Release: 2024

Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab.

Issue Release: 2024

Progressive Multifocal Leukoencephalopathy confined to the posterior fossa as the presenting manifestation of HIV in a paediatric patient.

Issue Release: 2024

Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing.

Issue Release: 2024

Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report.

Issue Release: 2024

Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Issue Release: 2024

Atypical Presentation of a Patient With Progressive Multifocal Leukoencephalopathy.

Issue Release: 2024

Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Issue Release: 2024

Progressive multifocal leukoencephalopathy as the presenting feature in a patient with occult low-count monoclonal B-cell lymphocytosis.

Issue Release: 2024

Progressive multifocal leukoencephalopathy with a benign prognosis in an immunocompetent patient - A case report.

Issue Release: 2024

Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies.

Issue Release: 2024

Exploring JC polyomavirus sequences and human gene expression in brain tissue of patients with progressive multifocal leukoencephalopathy.

Issue Release: 2024

High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.

Issue Release: 2024

Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis.

Issue Release: 2024

Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging.

Issue Release: 2024

What are the Symptoms of Diseases Transmitted by Aedes Albopictus?

How does it spread?

What are the Common Barriers to Vaccination?

What are the Implications of Genomics for Treatment?

Who Should Get Regular Health Check-Ups?

What Does a Regular Health Check-Up Entail?

How Are Bacterial Infections Diagnosed?

What is Cervical Cancer?

How Do Contaminants Enter Food and Water?

What are the Challenges in Infectious Disease Education?

Partnered Content Networks

Relevant Topics